Tokyo Tape
Sign in
← Tohoku Chemical

Quarterly report · Q1

7446.TEDINET S100ST6L
Period2023-10-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥8.3bn2023-10-01 → 2023-12-31Cons.Net sales
Revenue¥35.1bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥9.4bn2022-10-01 → 2022-12-31Cons.Net sales
Operating income¥58m2023-10-01 → 2023-12-31Cons.Operating income
Operating income¥254m2022-10-01 → 2022-12-31Cons.Operating income
Ordinary income¥78m2023-10-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥808m2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥271m2022-10-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥90m2023-10-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥271m2022-10-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥53m2023-10-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥556m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥182m2022-10-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥53m2023-10-01 → 2023-12-31Cons.Profit loss
Net income¥187m2022-10-01 → 2022-12-31Cons.Profit loss
Total assets¥19.7bnat 2023-12-31Cons.Assets
Total assets¥18.9bnat 2023-09-30Cons.Assets
Total assets¥19.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥12.4bnat 2023-12-31Cons.Liabilities
Total liabilities¥11.7bnat 2023-09-30Cons.Liabilities
Net assets / equity¥7.3bnat 2023-12-31Cons.Net assets
Net assets / equity¥7.3bnat 2023-09-30Cons.Net assets
Net assets / equity¥6.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.3bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥2.2bnat 2023-09-30Cons.Cash and deposits
EPS (basic)¥59.342023-10-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥617.292022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥202.312022-10-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio36.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segmentrevenue2023-10-01 → 2023-12-31¥518m
jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segmentrevenue external2023-10-01 → 2023-12-31¥518m
jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segmentrevenue2023-10-01 → 2023-12-31¥4.2bn
jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segmentrevenue external2023-10-01 → 2023-12-31¥4.2bn
jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segmentrevenue2023-10-01 → 2023-12-31¥3.6bn
jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segmentrevenue external2023-10-01 → 2023-12-31¥3.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2023-12-31¥8.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2023-12-31¥8.3bn
jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segmentrevenue2022-10-01 → 2022-12-31¥552m
jpcrp040300-q1r_E02810-000Academia Life Science Sales Groupreportable segmentrevenue external2022-10-01 → 2022-12-31¥552m
jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segmentrevenue2022-10-01 → 2022-12-31¥4.6bn
jpcrp040300-q1r_E02810-000Industry Sales Groupreportable segmentrevenue external2022-10-01 → 2022-12-31¥4.6bn
jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segmentrevenue2022-10-01 → 2022-12-31¥4.3bn
jpcrp040300-q1r_E02810-000Medical Sales Groupreportable segmentrevenue external2022-10-01 → 2022-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2022-12-31¥9.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2022-12-31¥9.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 365
ItemContextValueUnit
Remeasurements of defined benefit plansPrior1YearInstant5057000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant5211000JPY
Valuation and translation adjustmentsPrior1YearInstant702836000JPY
Valuation and translation adjustmentsCurrentQuarterInstant753212000JPY
Non controlling interestsPrior1YearInstant86867000JPY
Non controlling interestsCurrentQuarterInstant85957000JPY
Net assetsPrior1YearInstant7269089000JPY
Net assetsCurrentQuarterInstant7277689000JPY
Liabilities and net assetsPrior1YearInstant18920740000JPY
Liabilities and net assetsCurrentQuarterInstant19681740000JPY
Net salesPrior1YTDDuration9409299000JPY
Net salesCurrentYTDDuration8330285000JPY
Cost of salesPrior1YTDDuration8539838000JPY
Cost of salesCurrentYTDDuration7570187000JPY
Gross profitPrior1YTDDuration869460000JPY
Gross profitCurrentYTDDuration760098000JPY
Selling general and administrative expensesPrior1YTDDuration615021000JPY
Selling general and administrative expensesCurrentYTDDuration702449000JPY
Operating incomePrior1YTDDuration254439000JPY
Operating incomeCurrentYTDDuration57648000JPY
Interest income noiPrior1YTDDuration855000JPY
Interest income noiCurrentYTDDuration72000JPY
Dividends income noiPrior1YTDDuration14148000JPY
Dividends income noiCurrentYTDDuration17297000JPY
Commission fee noiPrior1YTDDuration2337000JPY
Commission fee noiCurrentYTDDuration2640000JPY
Other noiPrior1YTDDuration2366000JPY
Other noiCurrentYTDDuration3788000JPY
Non operating incomePrior1YTDDuration19707000JPY
Non operating incomeCurrentYTDDuration23798000JPY
Interest expenses noePrior1YTDDuration405000JPY
Interest expenses noeCurrentYTDDuration443000JPY
Commission fee noePrior1YTDDuration2124000JPY
Commission fee noeCurrentYTDDuration344000JPY
Miscellaneous loss noePrior1YTDDuration207000JPY
Miscellaneous loss noeCurrentYTDDuration2816000JPY
Non operating expensesPrior1YTDDuration2737000JPY
Non operating expensesCurrentYTDDuration3604000JPY
Ordinary incomePrior1YTDDuration271409000JPY
Ordinary incomeCurrentYTDDuration77842000JPY
Gain on sales of investment securities eiPrior1YTDDuration－JPY
Gain on sales of investment securities eiCurrentYTDDuration14904000JPY
Gain on investments in partnership eiPrior1YTDDuration－JPY
Gain on investments in partnership eiCurrentYTDDuration16000JPY
Extraordinary incomePrior1YTDDuration－JPY
Extraordinary incomeCurrentYTDDuration14921000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration－JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration3034000JPY
Extraordinary lossPrior1YTDDuration－JPY
Extraordinary lossCurrentYTDDuration3034000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-09-30pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass